메뉴 건너뛰기




Volumn 32, Issue 2, 2000, Pages 363-364

HLA-A2 transgenic mouse model: Potential utility for development of an HCV vaccine [2]

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

EID: 0033961859     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80087-2     Document Type: Letter
Times cited : (5)

References (7)
  • 1
    • 0032915550 scopus 로고    scopus 로고
    • DNA vaccine strategies for hepatitis C
    • G Inchauspé DNA vaccine strategies for hepatitis C J Hepatol 30 1999 339 346
    • (1999) J Hepatol , vol.30 , pp. 339-346
    • Inchauspé, G1
  • 2
    • 0030971268 scopus 로고    scopus 로고
    • HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice
    • S Pascolo N Bervas JM Ure AG Smith FA Lemonnier B Perarnau HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice J Exp Med 185 1997 2043 2051
    • (1997) J Exp Med , vol.185 , pp. 2043-2051
    • Pascolo, S1    Bervas, N2    Ure, JM3    Smith, AG4    Lemonnier, FA5    Perarnau, B6
  • 3
    • 0024503578 scopus 로고
    • Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element
    • AX Le EJ Bernhard MJ Holterman S Strub P Parham E Lacy Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element J Immunol 142 1989 1366 1371
    • (1989) J Immunol , vol.142 , pp. 1366-1371
    • Le, AX1    Bernhard, EJ2    Holterman, MJ3    Strub, S4    Parham, P5    Lacy, E6
  • 4
    • 0028038280 scopus 로고
    • Sequence analysis of the core gene of 14 hepatitis C virus genotypes
    • J Bukh RH Purcell RH Miller Sequence analysis of the core gene of 14 hepatitis C virus genotypes Proc Natl Acad Sci USA 91 1994 8239 8243
    • (1994) Proc Natl Acad Sci USA , vol.91 , pp. 8239-8243
    • Bukh, J1    Purcell, RH2    Miller, RH3
  • 5
    • 0030671121 scopus 로고    scopus 로고
    • Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
    • KM Chang B Rehermann JG McHutchison C Pasquinelli S Southwood A Sette Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus J Clin Invest 100 1997 2376 2385
    • (1997) J Clin Invest , vol.100 , pp. 2376-2385
    • Chang, KM1    Rehermann, B2    McHutchison, JG3    Pasquinelli, C4    Southwood, S5    Sette, A6
  • 6
    • 0028962927 scopus 로고
    • Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
    • M Battegay J Fikes AM Di Bisceglie PA Wentworth A Sette E Celis Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules J Virol 69 1995 2462 2470
    • (1995) J Virol , vol.69 , pp. 2462-2470
    • Battegay, M1    Fikes, J2    Di Bisceglie, AM3    Wentworth, PA4    Sette, A5    Celis, E6
  • 7
    • 0032785706 scopus 로고    scopus 로고
    • Targeting of hepatitis C virus core protein for MHC I or II presentation does not enhance the induction of immune response following DNA vaccination
    • O Vidalin E Takana U Spengler C Trépo G Inchauspé Targeting of hepatitis C virus core protein for MHC I or II presentation does not enhance the induction of immune response following DNA vaccination DNA Cell Biol 18 1999 611 621
    • (1999) DNA Cell Biol , vol.18 , pp. 611-621
    • Vidalin, O1    Takana, E2    Spengler, U3    Trépo, C4    Inchauspé, G5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.